Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer Disease 10”

37 trials

Showing 20 of 37 results

Not applicableStudy completedNCT05637801
What this trial is testing

A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)

Who this might be right for
Alzheimer DiseaseAlzheimer Disease 1Alzheimer Disease 2+32 more
Cognito Therapeutics, Inc. 673
Post-approval studies (Phase 4)Study completedNCT00305903
What this trial is testing

Safety and Tolerability of Rivastigmine With Add-on Memantine in Patients With Probable Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Novartis 150
Early research (Phase 1)Study completedNCT00494962
What this trial is testing

Study Comparing Lecozotan SR Two 5-mg Tablets Vs. Lecozotan SR One 10-mg Tablet in Healthy Subjects

Who this might be right for
Alzheimer Disease
Wyeth is now a wholly owned subsidiary of Pfizer 40
Early research (Phase 1)Study completedNCT01565330
What this trial is testing

Two Doses of 18F-AV-45 in Alzheimer's Disease and Healthy Volunteers

Who this might be right for
Alzheimer Disease
Avid Radiopharmaceuticals 20
Post-approval studies (Phase 4)Study completedNCT01529619
What this trial is testing

Efficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease Switched From Cholinesterase Inhibitors

Who this might be right for
Alzheimer's Disease
Novartis Pharmaceuticals 52
Large-scale testing (Phase 3)Study completedNCT00506415
What this trial is testing

Comparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm^2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive Decline

Who this might be right for
Alzheimer Disease
Novartis Pharmaceuticals 1,584
Large-scale testing (Phase 3)Study completedNCT00818662
What this trial is testing

Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild-to-Moderate Alzheimer´s Disease

Who this might be right for
Alzheimer´s Disease
Baxalta now part of Shire 390
Testing effectiveness (Phase 2)Study completedNCT00141661
What this trial is testing

A Safety and Tolerability Evaluation of Two 10-Week Dose Regimens of Orally-Administered PF-04494700 in Alzheimer's Patients

Who this might be right for
Alzheimer Disease
Pfizer 67
Large-scale testing (Phase 3)Ended earlyNCT01736579
What this trial is testing

Long-Term Study of IGIV, 10% in Alzheimer´s Disease

Who this might be right for
Alzheimer´s Disease
Baxalta now part of Shire 6
Large-scale testing (Phase 3)Study completedNCT00478205
What this trial is testing

Comparison of 23 mg Donepezil Sustained Release (SR) to 10 mg Donepezil Immediate Release (IR) in Patients With Moderate to Severe Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Eisai Inc. 1,467
Large-scale testing (Phase 3)Ended earlyNCT01739348
What this trial is testing

An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)

Who this might be right for
Alzheimer's Disease
Merck Sharp & Dohme LLC 2,211
Testing effectiveness (Phase 2)Study completedNCT00165659
What this trial is testing

A Multi-Center, Randomized, Double-Blind, Parallel Group Study With 3 Groups Receiving Placebo, 5 mg of E2020 and 10 mg of E2020

Who this might be right for
Alzheimer Disease
Eisai Limited
Post-approval studies (Phase 4)Study completedNCT00234637
What this trial is testing

Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor Treatment

Who this might be right for
Alzheimer's Disease
Novartis 204
Post-approval studies (Phase 4)Study completedNCT02703636
What this trial is testing

NextStep:Study to Evaluate Safety,Efficacy & Tolerability of Rivastigmine Patch in Mild to Moderate Alzheimer's Patients.

Who this might be right for
Mild to Moderate Alzheimer's Disease
Novartis Pharmaceuticals 118
Post-approval studies (Phase 4)Study completedNCT00561392
What this trial is testing

Clinical Effectiveness of 10 cm^2 Rivastigmine Patch in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Novartis 208
Early research (Phase 1)Ended earlyNCT01072812
What this trial is testing

Study of the Pharmacokinetics and Pharmacodynamics of POSIPHEN® in Subjects With Amnestic Mild Cognitive Impairment

Who this might be right for
Alzheimer's DiseaseAmnestic Mild Cognitive Impairment
Annovis Bio Inc. 5
Large-scale testing (Phase 3)Study completedNCT01614886
What this trial is testing

Randomized, Double-blind Study to Evaluate the Tolerability of 2 Different Titration Methods of Rivastigmine Patch in AD Patients (MMSE 10-20)

Who this might be right for
Alzheimer's Disease
Novartis Pharmaceuticals 216
Large-scale testing (Phase 3)Active Not RecruitingNCT06125951
What this trial is testing

Effect of 10 mg Xanamem on Dementia Due to Alzheimer's Disease

Who this might be right for
Dementia ModerateDementia, MildAlzheimer Disease
Actinogen Medical 247
Testing effectiveness (Phase 2)Study completedNCT00104273
What this trial is testing

Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD)

Who this might be right for
DementiaAlzheimer's Disease
Teva Branded Pharmaceutical Products R&D, Inc. 376
Large-scale testing (Phase 3)Study completedNCT02550665
What this trial is testing

Optimal Dose Escalation Strategy to Successful Achievement of High Dose Donepezil 23mg

Who this might be right for
Alzheimer's Disease
Asan Medical Center 176
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation